Stock RAPT RAPT THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions RAPT Therapeutics, Inc.

Equities

RAPT

US75382E1091

Market Closed - Nasdaq
Other stock markets
 02:00:00 07/05/2024 am IST 		5-day change 1st Jan Change
8.28 USD -0.60% Intraday chart for RAPT Therapeutics, Inc. +5.08% -66.68%
09/04 RAPT Therapeutics Announces Promising Results from Phase 2 Trial of Tivumecirnon in Combination with Anti-PD-1 Immunotherapy in CPI-Experienced Head and Neck Cancer Patients CI
27/03 JPMorgan Lowers RAPT Therapeutics' Price Target to $13 From $15, Keeps Neutral Rating MT

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Dividend / Share (DPS) - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Dividend / Share (DPS)

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. RAPT Stock
  4. Revisions RAPT Therapeutics, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW